ShareHope Medicine Co Ltd (8403) - Total Liabilities
Based on the latest financial reports, ShareHope Medicine Co Ltd (8403) has total liabilities worth NT$2.75 Billion TWD (≈ $86.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 8403 cash generation efficiency to assess how effectively this company generates cash.
ShareHope Medicine Co Ltd - Total Liabilities Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check ShareHope Medicine Co Ltd (8403) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
ShareHope Medicine Co Ltd Competitors by Total Liabilities
The table below lists competitors of ShareHope Medicine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avgol Industries 1953 Ltd
TA:AVGL
|
Israel | ILA256.81 Million |
|
Raonsecure Co. Ltd
KQ:042510
|
Korea | ₩20.77 Billion |
|
Gan Ltd
NASDAQ:GAN
|
USA | $91.63 Million |
|
Kabra Extrusion Technik Limited
NSE:KABRAEXTRU
|
India | Rs3.47 Billion |
|
Kyobo With Special Purpose Acq
KQ:205100
|
Korea | ₩9.30 Billion |
|
Alithya Group Inc
NASDAQ:ALYAF
|
USA | $218.38 Million |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
Malaysia | RM128.30 Million |
|
Sucro Limited
V:SUGR
|
Canada | CA$490.88 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down ShareHope Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ShareHope Medicine Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ShareHope Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ShareHope Medicine Co Ltd (2017–2024)
The table below shows the annual total liabilities of ShareHope Medicine Co Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$3.12 Billion ≈ $98.32 Million |
-10.59% |
| 2023-12-31 | NT$3.49 Billion ≈ $109.96 Million |
+6.45% |
| 2022-12-31 | NT$3.28 Billion ≈ $103.30 Million |
+47.06% |
| 2021-12-31 | NT$2.23 Billion ≈ $70.24 Million |
+5.84% |
| 2020-12-31 | NT$2.11 Billion ≈ $66.37 Million |
+39.17% |
| 2019-12-31 | NT$1.51 Billion ≈ $47.69 Million |
+17.57% |
| 2018-12-31 | NT$1.29 Billion ≈ $40.56 Million |
-2.04% |
| 2017-12-31 | NT$1.31 Billion ≈ $41.41 Million |
-- |
About ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more